The uptake levels of both Chol‐pyro NCP and Ce6 NCP by murine CRC MC38 cells decreased with LDLR blockade by an anti‐LDLR antibody (α‐LDLR) in a dose‐proportional manner (Figure 3a,b). The gene discussed is LDLR; the disease is colorectal carcinoma.